These results suggest that KPNB1 inhibition-upregulated cell surface DR5 mainly amplifies the death receptor signaling transduction favoring TRAIL-triggered apoptosis in tested glioblastoma cells. The gene discussed is KPNB1; the disease is glioblastoma.